During a speech at HLTH 2024, Jill Biden announced that 23 recipients have been chosen for ARPA-H’s Sprint for Women’s Health. The recipients address issues like cancer, ovarian health and gynecological care. The post ARPA-H Awards $110M to 23 Startups and Innovators In Women’s Health, Jill Biden Announces appeared first on MedCity News.
A panel of experts said the HLTH conference agrred that states with strict abortion measures are likely to see negative economic impact as medical residents decline to go to them for training and physicians move out. The post Strict Abortion Laws Is Likely Already Having An Economic Impact appeared first on MedCity News.
Here are nine notable announcements shared at the HLTH conference held this week in Las Vegas. The post 9 HLTH Announcements You Don’t Want to Miss appeared first on MedCity News.
In a series of articles to promote INVEST 2025 in Chicago April 29-30, we are highlighting investment insights and perspectives in the runup to the boutique event for traditional and strategic healthcare investors and startups. Register today! The post Springboard Enterprises Executive-in-Residence Shares Advice to Startups appeared first on MedCity News.
Fourteen maternal-fetal medicine-focused universities and healthcare systems across the state are participating in SOS Maternity
Platform being co-developed by Commure and HCA Healthcare is designed to support critical workflows in emergency departments, hospitalist operations, and ambulatory care
FarmboxRx CEO Ashley Tyrner explains why she never accepted outside capital after launching her company that serves nutritional needs of Medicaid and Medicare members. The post Video: Why This Startup CEO Never Accepted Outside Capital appeared first on MedCity News.
Tennessee-based Compassus has formed similar joint ventures with Ascension, Bon Secours Mercy Health and OhioHealth
An Alto drug candidate for major depressive disorder failed to meet primary and secondary goals of a placebo-controlled Phase 2b test. The disappointing result could stymie plans for further tests of the small molecule in PTSD and bipolar depression. The post Alto Neuroscience’s Depression Trial Failure Sends Shares Into Downward Spiral appeared first on MedCity…
For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the side effects, it’s important for healthcare providers to offer education on herbal alternatives and consider these as part of the broader treatment conversation. The post Can Herbal Alternatives Ease the Economic Burden of Weight Loss…